Trial
NCT02114528
Anti-arrhythmic Therapy vs Catheter Ablation as First Line Treatment for AICD Shock Prevention
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Ottawa Heart Institute Research Corporation
Collaborators
—
Condition
Ventricular Tachycardia
Intervention
Antiarrhythmic Drug Therapy
Why stopped
Low recruitment. Pilot trial.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-05-04